In some embodiments, the present invention provides methods for determining the risk of a cardiovascular disease, for assessing risk of a cardiovascular disease, and/or for determining the risk of heart attack.

Determining the credit risk and the credit buffer by HFF

Methods for determining risk of developing breast cancer are described.

Determining credit risk from driving behavior.

A method of determining risk of diabetes is provided.

The invention also provides for determining the risk or susceptibility to adverse events upon receipt of therapy.

A method (100) of determining cumulative absolute risk of breast cancer for a woman is disclosed.

Following determination of a credit risk by HFF, the book value is not immediately reduced by the value of the credit risk.

A method of determining risk of cancer in a mammal is provided.

Also provided is a kit for determining the risk of a urologic event.

Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.

The invention also describes methods of determining the risk of a subject to various conditions.

Methods of determining risk of CNS disorders and methods of determining treatment response are also described.

This possibly safeguards against such scenarios having too much of an influence in determining the overall risk of the product.

This possibly safeguards against such scenarios having too much of an influence in determining the overall risk of the product.